Early-stage elephantiasis in bancroftian filariasis.
Grobusch
M P
MP
Department of Infectious Diseases, Charité, Humboldt University, Berlin, Germany. martin.grobusch@uni-tuebingen.de
Göbels
K
K
Teichmann
D
D
Bergmann
F
F
Suttorp
N
N
D000328:Adult; D015766:Albendazole / Q000008:administration & dosage; D000818:Animals; D003906:Developing Countries; D004359:Drug Therapy, Combination; D004605:Elephantiasis, Filarial / Q000175:diagnosis* / Q000188:drug therapy; D019353:Endemic Diseases; D005369:Filaricides / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage; D008297:Male; D018570:Risk Assessment; D012720:Severity of Illness Index; D013019:South Africa; D014195:Travel; D016896:Treatment Outcome; D014958:Wuchereria bancrofti / Q000302:isolation & purification*
D005369:Filaricides; D007559:Ivermectin; D015766:Albendazole